The anti-inflammatory effect of opioids. 1994

A Gavalas, and P Victoratos, and M Yiangou, and L Hadjipetrou-Kourounakis, and E Rekka, and P Kourounakis
Laboratory of Medicinal Chemistry, School of Pharmacy, Faculty of Health, Aristoteles University, Thessaloniki, Greece.

The anti-inflammatory activity of two novel opioids PM and PO as well as of pethidine was studied. The mouse paw edema, induced by various phlogistic agents, was significantly inhibited after the administration of opioids, fact that was independent of their antioxidant properties. The anti-inflammatory action of the above opioids was not reversed by naloxone. These results suggest that a variety of complex regulatory activities may be performed by opioid agonists via naloxone-sensitive or naloxone insensitive receptors on inflammatory cells, directly or indirectly by the inhibition of cytokines and mediators involved in inflammation.

UI MeSH Term Description Entries
D008614 Meperidine A narcotic analgesic that can be used for the relief of most types of moderate to severe pain, including postoperative pain and the pain of labor. Prolonged use may lead to dependence of the morphine type; withdrawal symptoms appear more rapidly than with morphine and are of shorter duration. Isonipecain,Pethidine,Demerol,Dolantin,Dolargan,Dolcontral,Dolin,Dolosal,Dolsin,Lidol,Lydol,Meperidine Hydrochloride,Operidine EPJ-I,Operidine EPJ I
D009270 Naloxone A specific opiate antagonist that has no agonist activity. It is a competitive antagonist at mu, delta, and kappa opioid receptors. MRZ 2593-Br,MRZ-2593,Nalone,Naloxon Curamed,Naloxon-Ratiopharm,Naloxone Abello,Naloxone Hydrobromide,Naloxone Hydrochloride,Naloxone Hydrochloride Dihydride,Naloxone Hydrochloride, (5 beta,9 alpha,13 alpha,14 alpha)-Isomer,Naloxone, (5 beta,9 alpha,13 alpha,14 alpha)-Isomer,Narcan,Narcanti,Abello, Naloxone,Curamed, Naloxon,Dihydride, Naloxone Hydrochloride,Hydrobromide, Naloxone,Hydrochloride Dihydride, Naloxone,Hydrochloride, Naloxone,MRZ 2593,MRZ 2593 Br,MRZ 2593Br,MRZ2593,Naloxon Ratiopharm
D009294 Narcotics Agents that induce NARCOSIS. Narcotics include agents that cause somnolence or induced sleep (STUPOR); natural or synthetic derivatives of OPIUM or MORPHINE or any substance that has such effects. They are potent inducers of ANALGESIA and OPIOID-RELATED DISORDERS. Analgesics, Narcotic,Narcotic Analgesics,Narcotic,Narcotic Effect,Narcotic Effects,Effect, Narcotic,Effects, Narcotic
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D004487 Edema Abnormal fluid accumulation in TISSUES or body cavities. Most cases of edema are present under the SKIN in SUBCUTANEOUS TISSUE. Dropsy,Hydrops,Anasarca
D005121 Extremities The farthest or outermost projections of the body, such as the HAND and FOOT. Limbs,Extremity,Limb
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000893 Anti-Inflammatory Agents Substances that reduce or suppress INFLAMMATION. Anti-Inflammatory Agent,Antiinflammatory Agent,Agents, Anti-Inflammatory,Agents, Antiinflammatory,Anti-Inflammatories,Antiinflammatories,Antiinflammatory Agents,Agent, Anti-Inflammatory,Agent, Antiinflammatory,Agents, Anti Inflammatory,Anti Inflammatories,Anti Inflammatory Agent,Anti Inflammatory Agents
D013154 Spleen An encapsulated lymphatic organ through which venous blood filters.
D015227 Lipid Peroxidation Peroxidase catalyzed oxidation of lipids using hydrogen peroxide as an electron acceptor. Lipid Peroxidations,Peroxidation, Lipid,Peroxidations, Lipid

Related Publications

A Gavalas, and P Victoratos, and M Yiangou, and L Hadjipetrou-Kourounakis, and E Rekka, and P Kourounakis
January 2003, Advances in experimental medicine and biology,
A Gavalas, and P Victoratos, and M Yiangou, and L Hadjipetrou-Kourounakis, and E Rekka, and P Kourounakis
October 2017, The Orthopedic clinics of North America,
A Gavalas, and P Victoratos, and M Yiangou, and L Hadjipetrou-Kourounakis, and E Rekka, and P Kourounakis
January 2000, The Journal of pharmacology and experimental therapeutics,
A Gavalas, and P Victoratos, and M Yiangou, and L Hadjipetrou-Kourounakis, and E Rekka, and P Kourounakis
January 1995, Life sciences,
A Gavalas, and P Victoratos, and M Yiangou, and L Hadjipetrou-Kourounakis, and E Rekka, and P Kourounakis
May 1999, The Veterinary clinics of North America. Small animal practice,
A Gavalas, and P Victoratos, and M Yiangou, and L Hadjipetrou-Kourounakis, and E Rekka, and P Kourounakis
January 2012, Canadian family physician Medecin de famille canadien,
A Gavalas, and P Victoratos, and M Yiangou, and L Hadjipetrou-Kourounakis, and E Rekka, and P Kourounakis
May 1997, European journal of anaesthesiology. Supplement,
A Gavalas, and P Victoratos, and M Yiangou, and L Hadjipetrou-Kourounakis, and E Rekka, and P Kourounakis
July 2020, Journal of dental research,
A Gavalas, and P Victoratos, and M Yiangou, and L Hadjipetrou-Kourounakis, and E Rekka, and P Kourounakis
December 2019, The Senior care pharmacist,
A Gavalas, and P Victoratos, and M Yiangou, and L Hadjipetrou-Kourounakis, and E Rekka, and P Kourounakis
January 2004, The Cochrane database of systematic reviews,
Copied contents to your clipboard!